Latest news with #JiangsuHengruiPharmaceuticalsCo.
Bloomberg
15-05-2025
- Business
- Bloomberg
Hengrui Pharma Seeks Up to $1.3 Billion in Hong Kong Listing
Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as HK$9.9 billion ($1.3 billion), the latest significant deal to boost the financial hub's share-sale recovery. The Chinese drugmaker is offering 225 million shares at HK$41.45 to HK$44.05 apiece, according to its listing document on Thursday. Versus Hengrui's last close in Shanghai on Wednesday, that's a discount of as much as 28% — roughly in line with what Hong Kong shares trade at relative to their mainland China-listed stocks.
Bloomberg
28-04-2025
- Business
- Bloomberg
Hengrui Pharma Gets China Regulator's Nod for Hong Kong Share Sale
Jiangsu Hengrui Pharmaceuticals Co. received the green light from China's securities regulator for its Hong Kong listing, putting the Chinese drugmaker a step closer to a share sale that may fetch as much as $2 billion. The Shanghai-listed company plans to issue up to 815 million shares in Hong Kong, Hengrui said in an exchange filing Monday. The sale could occur as soon as this year, people familiar with the matter have said.
